United States: Janssen V. Teva: Not An April Fool's Day Joke For Life Sciences Companies - Goodwin Procter LLP
Published
On April 1, 2024, the Federal Circuit released its opinion in Janssen Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al., affirming the district court's finding that certain claims were not indefinite and remanding to the district court to reevaluate its obviousness decision.
Full Article